As of 2:30 PM on the 9th, Access Bio is trading at 28,500 KRW, down 6.1% from the previous day. This represents a 42.71% decline compared to August 19. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net purchased 7,809 shares, while foreigners and institutions have net purchased 7,339 shares and 3,906 shares, respectively.
On September 7, Access Bio became a market topic with the headline "Rising Trend Due to Re-evaluation of COVID-19 Antibody Diagnostic Kits."
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
